 |
 |

Association of Interleukin-4 Plasma Levels With Traumatic Injury and Clinical Course
Joseph T. DiPiro, PharmD;
Thomas R. Howdieshell, MD;
Julie K. Goddard, PharmD;
Dianne B. Callaway;
Robert G. Hamilton, PhD;
Arlie R. Mansberger, Jr, MD
Arch Surg. 1995;130(11):1159-1163.
Abstract
 |  |
Objectives To determine if interleukin-4 (IL-4) could be detected in plasma of trauma patients and if IL-4 activity is associated with patterns of clinical events, complications, or outcomes.
Methods A prospective case series conducted in a tertiary care referral center with a level I trauma center. One hundred patients admitted to the trauma intensive care unit for at least 3 days were included. Plasma concentrations of IL-4 and IgE were determined from admission to intensive care unit discharge. Data on clinical outcome were collected, including death, sepsis, severe sepsis, adult respiratory distress syndrome, pneumonia, and renal dysfunction.
Results Interleukin-4 was detected in the plasma of 87 patients. Patients with an Injury Severity Score of greater than 25 had higher admission IL-4 levels (P=.03) and greater maximal IL-4 levels (P<.001). Admission hypotension (P=.04) and age 30 years or younger (P<.001) were also associated with higher admission IL-4 levels. Increases in IL-4 levels were significantly greater for patients in whom sepsis, severe sepsis, or pneumonia developed (P<.05). A low admission IL-4 level was associated with a greater incidence of nosocomial pneumonia (P<.001). Additional indirect evidence of IL-4 activation included increased plasma IgE levels.
Conclusions Anti-inflammatory cytokine mechanisms are activated after injury and are associated with the development of infectious complications (sepsis, severe sepsis, and pneumonia). Exogenous administration of interleukin-4 should be evaluated as an experimental therapeutic approach after trauma and associated sepsis.
(Arch Surg. 1995;130:1159-1163)
Author Affiliations
From the University of Georgia College of Pharmacy, Athens (Drs DiPiro and Goddard); the Department of Surgery, The Medical College of Georgia, Augusta (Drs DiPiro, Howdieshell, and Mansberger and Ms Callaway); and the Asthma and Allergy Center, The Johns Hopkins University School of Medicine, Baltimore, Md (Dr Hamilton).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Cutting Edge: B Cell Receptor (BCR) Cross-Talk: The IL-4-Induced Alternate Pathway for BCR Signaling Operates in Parallel with the Classical Pathway, Is Sensitive to Rottlerin, and Depends on Lyn
Guo et al.
J. Immunol. 2007;178:4726-4730.
ABSTRACT
| FULL TEXT
Burn Wound Infections
Church et al.
Clin. Microbiol. Rev. 2006;19:403-434.
ABSTRACT
| FULL TEXT
B Cell Receptor (BCR) Cross-Talk: IL-4 Creates an Alternate Pathway for BCR-Induced ERK Activation That Is Phosphatidylinositol 3-Kinase Independent
Guo and Rothstein
J. Immunol. 2005;174:5375-5381.
ABSTRACT
| FULL TEXT
Jaks, STATs, Cytokines, and Sepsis
Scott et al.
CVI 2002;9:1153-1159.
FULL TEXT
Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators
Loomis et al.
Am. J. Physiol. Cell Physiol. 2001;281:C840-C848.
ABSTRACT
| FULL TEXT
Interferon-{gamma} counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass
Flohe et al.
Innate Immunity 2000;6:431-436.
ABSTRACT
The Potential Pattern of Circulating Lymphocytes TH1/TH2 Is Not Altered After Multiple Injuries
Wick et al.
Arch Surg 2000;135:1309-1314.
ABSTRACT
| FULL TEXT
Tolerant B Lymphocytes Acquire Resistance to Fas-mediated Apoptosis after Treatment with Interleukin 4 but Not after Treatment with Specific Antigen Unless a Surface Immunoglobulin Threshold Is Exceeded
Foote et al.
JEM 1998;187:847-853.
ABSTRACT
| FULL TEXT
Inhibition of the Defense System Stimulating Interleukin-12 Interferon-gamma Pathway During Critical Illness
Ertel et al.
Blood 1997;89:1612-1620.
ABSTRACT
| FULL TEXT
Dominance of T-Helper 2-Type Cytokines After Severe Injury
Mack et al.
Arch Surg 1996;131:1303-1309.
ABSTRACT
|